Notwithstanding, our results show that, at least in BCP-ALL and lymphoblastoid cells, the MEK signaling engages the NF-κB pathway in DNA damaged cells only when cAMP signaling is activated. This evidence concerns the gene NFKB1 and acute lymphoblastic leukemia.